Morningstar Rating

ETF Research and Analysis

by Robert Goldsborough
Suitability
First Trust Health Care AlphaDEX FXH should be treated as a complementary satellite holding to a diversified portfolio. This exchange-traded fund holds a portfolio of 76 health-care stocks.
Unlike most passive funds, which   Read more 

Bull Case

This ETF offers much more of a mid-cap tilt than other health-care ETFs. As such, we believe it provides purer exposure to the U.S. health-care sector than do some of its peers, whose holdings include large-cap pharmaceutical companies with meaningful overseas businesses.
Given litigation worries in the health-care sector, an ETF is an effective vehicle for diversifying away much of the company-specific risk.
The health-care exchanges are expected to provide modest benefits at a minimum to several important health-care subsectors, including pharmaceutical firms, health-care providers, MCOs, and PBMs. Read more 

Bear Case

The defensive nature of the businesses included in this ETF may mitigate the downside in a severe economic downturn, but that doesn't mean investors won't experience periods of negative returns.
Health-care stock prices, drug stocks in particular, can be very sensitive to the notion of increased governmental regulation of prices. Tackling the rising expense of health care is increasingly a priority for politicians.
The health-care sector is exposed to large systematic risks related to government policy. If the government enacts policies that reduce profitability across the health-care sector (or among drugmakers in particular), this ETF will suffer. Read more 

Reduce Volatility and Increase Yield With This ETF 
Watch more 

Premium Membership

View all of our analyst reports with a free trial to Morningstar.com Premium.